Type 2 Diabetes Mellitus Completed Phase 4 Trials for Cilostazol (DB01166)

Also known as: Non-Insulin-Dependent Diabetes Mellitus / Type 2 Diabetes Mellitus (T2DM) / Type 2 Diabetes / Diabetes, Type II / Type II Diabetes Mellitus / T2DM / Type Two Diabetes Mellitus / Diabetes mellitus non-insulin-dependent / NIDDM / Diabetes mellitus: [adult onset] or [noninsulin dependent] / Diabetes mellitus type 2 (disorder) / Diabetes mellitus: [adult onset, with no mention of complication] or [maturity onset] or [non-insulin dependent] / Diabetes Mellitus, Type 2 / Diabetes mellitus non insulin-dep / Maturity onset diabetes / Diabetes mellitus maturity onset

IndicationStatusPhase
DBCOND0029752 (Type 2 Diabetes Mellitus)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02983214Diabetic Artery Obstruction: is it Possible to Reduce Ischemic Events With Cilostazol?Health Services Research
NCT00272831The Use of Cilostazol in Patients With Diabetic NephropathyTreatment
NCT00823849Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related BiomarkerTreatment
NCT03248401Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 DiabetesTreatment